Related references
Note: Only part of the references are listed.
Review
Critical Care Medicine
Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis
Ryan Ruiyang Ling et al.
Summary: The overall risk of myopericarditis after receiving a COVID-19 vaccine is low, but younger males have an increased incidence of myopericarditis, especially after receiving mRNA vaccines. However, the risks of such rare adverse events should be balanced against the risks of COVID-19 infection (including myopericarditis).
LANCET RESPIRATORY MEDICINE (2022)
Article
Rheumatology
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study
Jochen Pfeifer et al.
Summary: Autoantibodies against IL-1Ra were observed in a high proportion of patients with MIS-C and may impair IL-1Ra function, leading to increased IL-1 beta signaling in MIS-C.
LANCET RHEUMATOLOGY (2022)
Article
Medicine, General & Internal
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
D. Mevorach et al.
Summary: The incidence of myocarditis increased after receiving the BNT162b2 vaccine in Israel, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Share Paper
